Cargando…

Understanding Vietnam’s drug policy for amphetamine-type stimulants misuse

INTRODUCTION: The emergence of widespread amphetamine-type stimulants (ATSs) usage has created significant challenges for drug control and treatment policies in Southeast Asian countries. This study analyses the development of drug policies and examines current treatment program constraints in Vietn...

Descripción completa

Detalles Bibliográficos
Autores principales: Tran, Mai Thi Ngoc, Dunne, Michael P., Minh Le, Giang, Han, Hoe Dinh, Nguyen, Trang Thu, Luong, Hai Thanh, Luong, Quang Hung, Pham, Ha Nguyen, Baker, Philip
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9103057/
https://www.ncbi.nlm.nih.gov/pubmed/35562829
http://dx.doi.org/10.1186/s12954-022-00621-9
_version_ 1784707472491020288
author Tran, Mai Thi Ngoc
Dunne, Michael P.
Minh Le, Giang
Han, Hoe Dinh
Nguyen, Trang Thu
Luong, Hai Thanh
Luong, Quang Hung
Pham, Ha Nguyen
Baker, Philip
author_facet Tran, Mai Thi Ngoc
Dunne, Michael P.
Minh Le, Giang
Han, Hoe Dinh
Nguyen, Trang Thu
Luong, Hai Thanh
Luong, Quang Hung
Pham, Ha Nguyen
Baker, Philip
author_sort Tran, Mai Thi Ngoc
collection PubMed
description INTRODUCTION: The emergence of widespread amphetamine-type stimulants (ATSs) usage has created significant challenges for drug control and treatment policies in Southeast Asian countries. This study analyses the development of drug policies and examines current treatment program constraints in Vietnam to deal with ATS misuse. The aim was to gain insights that may be useful for national and international drug-related policy development and revision. METHODS: A desk review of national policy documents and 22 in-depth key informant interviews were conducted from 2019 to 2021. Thematic content analysis was employed to identify key themes and their connections. RESULTS: Analysis identified Vietnam’s 30-year history of developing policies and formulating strategies to reduce supply, demand, and harm from illicit drugs. With the increasing number of people who use ATS (PWUA), Vietnam has recently promoted harsh policy and law enforcement to deter drug use and supply. This policy trend prevails in many Asian countries. The three main constraints in dealing with ATS misuse emerged from punitive and restrictive drug policies. First, the general public believed that Centre-based compulsory treatment (CCT) is the only appropriate treatment for all types of illicit drug addiction despite its low-quality service provision. The rigid drug policy has led to social persuasion with impractical expectations for CCT effectiveness. Second, the emphasis on punishment and detention has hampered new drug treatment service development in Vietnam. CCT has become monopolistic in the context of impoverished services. Third, people who use drugs tend to hide their needs and avoid formal treatment and support services, resulting in declined social coherence. CONCLUSION: While new drugs are constantly evolving, the current law enforcement approach potentially constrains expertise to adopt effective treatment services. This study suggests that the top-down policing mechanism presently hinders the development of an appropriate intervention strategy for ATS misuse and diminishes social support to service providers.
format Online
Article
Text
id pubmed-9103057
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-91030572022-05-14 Understanding Vietnam’s drug policy for amphetamine-type stimulants misuse Tran, Mai Thi Ngoc Dunne, Michael P. Minh Le, Giang Han, Hoe Dinh Nguyen, Trang Thu Luong, Hai Thanh Luong, Quang Hung Pham, Ha Nguyen Baker, Philip Harm Reduct J Research INTRODUCTION: The emergence of widespread amphetamine-type stimulants (ATSs) usage has created significant challenges for drug control and treatment policies in Southeast Asian countries. This study analyses the development of drug policies and examines current treatment program constraints in Vietnam to deal with ATS misuse. The aim was to gain insights that may be useful for national and international drug-related policy development and revision. METHODS: A desk review of national policy documents and 22 in-depth key informant interviews were conducted from 2019 to 2021. Thematic content analysis was employed to identify key themes and their connections. RESULTS: Analysis identified Vietnam’s 30-year history of developing policies and formulating strategies to reduce supply, demand, and harm from illicit drugs. With the increasing number of people who use ATS (PWUA), Vietnam has recently promoted harsh policy and law enforcement to deter drug use and supply. This policy trend prevails in many Asian countries. The three main constraints in dealing with ATS misuse emerged from punitive and restrictive drug policies. First, the general public believed that Centre-based compulsory treatment (CCT) is the only appropriate treatment for all types of illicit drug addiction despite its low-quality service provision. The rigid drug policy has led to social persuasion with impractical expectations for CCT effectiveness. Second, the emphasis on punishment and detention has hampered new drug treatment service development in Vietnam. CCT has become monopolistic in the context of impoverished services. Third, people who use drugs tend to hide their needs and avoid formal treatment and support services, resulting in declined social coherence. CONCLUSION: While new drugs are constantly evolving, the current law enforcement approach potentially constrains expertise to adopt effective treatment services. This study suggests that the top-down policing mechanism presently hinders the development of an appropriate intervention strategy for ATS misuse and diminishes social support to service providers. BioMed Central 2022-05-13 /pmc/articles/PMC9103057/ /pubmed/35562829 http://dx.doi.org/10.1186/s12954-022-00621-9 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Tran, Mai Thi Ngoc
Dunne, Michael P.
Minh Le, Giang
Han, Hoe Dinh
Nguyen, Trang Thu
Luong, Hai Thanh
Luong, Quang Hung
Pham, Ha Nguyen
Baker, Philip
Understanding Vietnam’s drug policy for amphetamine-type stimulants misuse
title Understanding Vietnam’s drug policy for amphetamine-type stimulants misuse
title_full Understanding Vietnam’s drug policy for amphetamine-type stimulants misuse
title_fullStr Understanding Vietnam’s drug policy for amphetamine-type stimulants misuse
title_full_unstemmed Understanding Vietnam’s drug policy for amphetamine-type stimulants misuse
title_short Understanding Vietnam’s drug policy for amphetamine-type stimulants misuse
title_sort understanding vietnam’s drug policy for amphetamine-type stimulants misuse
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9103057/
https://www.ncbi.nlm.nih.gov/pubmed/35562829
http://dx.doi.org/10.1186/s12954-022-00621-9
work_keys_str_mv AT tranmaithingoc understandingvietnamsdrugpolicyforamphetaminetypestimulantsmisuse
AT dunnemichaelp understandingvietnamsdrugpolicyforamphetaminetypestimulantsmisuse
AT minhlegiang understandingvietnamsdrugpolicyforamphetaminetypestimulantsmisuse
AT hanhoedinh understandingvietnamsdrugpolicyforamphetaminetypestimulantsmisuse
AT nguyentrangthu understandingvietnamsdrugpolicyforamphetaminetypestimulantsmisuse
AT luonghaithanh understandingvietnamsdrugpolicyforamphetaminetypestimulantsmisuse
AT luongquanghung understandingvietnamsdrugpolicyforamphetaminetypestimulantsmisuse
AT phamhanguyen understandingvietnamsdrugpolicyforamphetaminetypestimulantsmisuse
AT bakerphilip understandingvietnamsdrugpolicyforamphetaminetypestimulantsmisuse